Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Stephanie A"


25 mentions found


Millions of People Booted From Medicaid After Pandemic
  + stars: | 2023-07-08 | by ( Stephanie Armour | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/millions-of-people-booted-from-medicaid-after-pandemic-1854b318
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/consumers-to-face-new-limits-on-private-short-term-health-insurance-2e943e7f
Persons: Dow Jones
How Apple Became a $3 Trillion Company
  + stars: | 2023-06-30 | by ( Stephanie Aaronson | Aaron Tilley | ) www.wsj.com   time to read: 1 min
Apple went public in 1980, the same year as the release of the Apple III computer, shown here. The company initially sold 4.6 million shares at $22 apiece; it now has about 15.7 billion shares that trade around $190 each. Vreeland/ClassicStock/Getty Images
Persons: Apple, Vreeland Organizations: Apple
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/green-card-backlog-fuels-shortage-of-nurses-at-hospitals-nursing-homes-4f0b0e44
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/u-s-becomes-transgender-care-outlier-as-more-in-europe-urge-caution-6c70b5e0
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/some-cancer-patients-must-travel-hundreds-of-miles-for-medication-adbc3248
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/debt-limit-bill-cancels-almost-30-billion-in-pandemic-relief-funding-98c2dbdc
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/president-biden-plans-to-name-mandy-cohen-as-cdc-director-32ba1e2d
Persons: Dow Jones, biden, cohen, 32ba1e2d
Medicare Plans to Cover Alzheimer’s Drugs
  + stars: | 2023-06-01 | by ( Stephanie Armour | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/medicare-plans-to-cover-alzheimers-drugs-ae709418
Persons: Dow Jones
Several measures from Friday's jobs report show the labor market is stronger than it's been in decades. But Terrazas pointed to potential concerns in the labor market and for interest rates. "If it's the former, it's just a matter of time before gravity catches up with the labor market," Terrazas said. Overall though, the different robust labor market data suggests the US could maybe avoid a recession as has been the case so far in 2023. Despite potential risks in the job market, Pollak believes there's a possibility that the US continues to avoid a recession.
Drug pricing is complicated and secretive. WSJ explains how the flow of money, drugs and rebates behind the scenes may drive up the price of prescription medicine for consumers. Illustration: Mallory BranganRepublicans and Democrats in Congress may find rare agreement in the coming months on legislation taking aim at high drug costs. The lawmakers are rolling out proposals that aim to reduce drug spending by insurers and government agencies, as well as by patients at the pharmacy trying to fill prescriptions for diabetes and other medicines.
Some have sought to toughen existing work requirements for food and cash assistance, as well as adding similar conditions to Medicaid eligibility. Photo: KEN CEDENO/REUTERSWASHINGTON—House Republicans are pushing to require more people seeking federal assistance to find jobs, thrusting a long-running debate over aid for poor Americans into the middle of a battle with Democrats over raising the debt limit. In legislation that passed the House on Wednesday with only GOP support, lawmakers moved to toughen existing work requirements for food and cash assistance, while proposing to add similar conditions to be eligible for Medicaid, a healthcare program for low-income and disabled people.
Transgender-rights advocates demonstrated in February at the Statehouse in Mississippi, where lawmakers moved to restrict some coverage for care of gender-transitioning patients. Photo: Rogelio V. Solis/Associated PressWASHINGTON—Medicaid is at the center of a widening partisan divide among states over transgender healthcare, where some Americans are denied access to gender-related treatments while others are seeing the availability of such care expand. The Medicaid insurance program, which covers more than 90 million low-income or disabled Americans, has become a way for states to signal sharply divergent positions on transgender-specific care. Republican-led states including Mississippi and Tennessee, where the GOP controls both legislative chambers and the governorship, have recently introduced legislation to restrict some coverage for care of gender-transitioning patients.
Preventive healthcare services include mammograms and cancer screenings. Photo: Heather Charles/Chicago Tribune/Getty ImagesThe majority of insurers in the U.S. don’t expect to drop no-cost preventive healthcare services as a lawsuit challenging the Affordable Care Act requirement works its way through the courts, according to a letter to lawmakers from the six trade groups representing the insurance industry. Their decision was outlined Wednesday in a letter by trade groups to House and Senate Democratic health committee leaders, who on April 12 wrote to a dozen of the nation’s largest health insurers and trade associations asking whether they intend to cover all recommended preventive services without cost-sharing until all appellate review in the case is concluded.
The vaccine will target both the Omicron variant and the original strain of the Covid-19 virus. Americans seeking messenger RNA vaccines for Covid-19 for the first time will get one, updated shot targeting both the Omicron variant and the original strain of the virus under new moves rolled out Tuesday by federal health officials. The Food and Drug Administration also authorized a second booster of the updated shots for people at high risk of Covid-19, specifically people 65 years and older or people who have weak immune systems.
Proposed telehealth rules call for in-person visit for online prescriptions of controlled-substance drugs such as buprenorphine, a medication for opioid-use disorder. WASHINGTON—A federal plan to resume tighter limits on the prescribing of controlled substances through telehealth has spurred a backlash from some medical and patient advocacy groups who say the requirements would create barriers to care. The organizations are urging the Drug Enforcement Administration to reconsider proposed rules that would let doctors remotely prescribe a 30-day supply of some drugs, including buprenorphine for opioid-use disorder, as well as ketamine and testosterone, but require at least one in-person visit for further prescriptions.
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/medicare-cracks-down-on-deceptive-advertising-service-denials-by-privately-run-plans-97bab94b
Hospital leaders worry they will be left covering the costs of more uninsured patients as millions of people lose Medicaid coverage. WASHINGTON—An unprecedented effort by states to review the eligibility of the more than 90 million people on Medicaid carries high financial stakes for industry groups, including hospitals that risk paying more to cover uninsured patients and insurers that could lose some of the money they get for managing state Medicaid programs. Eligibility reviews for people who get Medicaid coverage were paused during the Covid-19 pandemic. The resumption of those reviews and disenrollment of people, technically starting Saturday, has industry working with federal regulators, patient advocacy groups and state Medicaid offices to urgently inform beneficiaries. All of them are working to tell enrollees what steps they can take to avoid losing coverage or how to secure other types of health insurance if they earn too much for the program.
Under the ACA, health plans must generally provide access to no-cost preventive care. WASHINGTON—A federal judge in Texas struck down a major part of the Affordable Care Act’s requirement that most insurers cover certain preventive health services, in a ruling that applies nationwide and will likely be appealed. Judge Reed O’Connor of the U.S. District Court for the Northern District of Texas issued on Thursday a nationwide injunction striking down the requirement that most commercial insurers fully cover dozens of preventive-care services and screenings recommended by a federal task force with no out-of-pocket consumer costs.
UnitedHealthcare said it would cut its use of the prior authorization process. The paperwork required by health insurers to get many medical procedures or tests—one of the biggest gripes of doctors and patients—is getting rolled back. UnitedHealth Group Inc.’s UnitedHealthcare, the largest health insurer in the U.S., said it would cut its use of the prior authorization process. Starting in the third quarter, it will remove many procedures and medical devices from its list requiring the signoff.
Humira, which treats rheumatoid-arthritis, is one of the 27 drugs named by U.S. health officials whose prices went up more than the rate of inflation. U.S. health officials released the first list of drugs paid for by the government’s Medicare insurance program whose prices went up more than the rate of inflation and and will face a penalty under a new federal law. The Centers for Medicare and Medicaid Services on Wednesday named 27 drugs that had the large price increases, including rheumatoid-arthritis treatment Humira from AbbVie Inc. and Yescarta lymphoma therapy from Gilead Sciences Inc., and will face the price-increase penalty in the form of a rebate.
Humira, for rheumatoid arthritis, is one of the drugs facing a price-increase penalty. U.S. health officials released the first list of drugs paid for by the government’s Medicare insurance program whose prices went up more than the rate of inflation and will face a penalty under a new federal law. The Centers for Medicare and Medicaid Services on Wednesday named 27 drugs that had the large price increases, including rheumatoid-arthritis treatment Humira from AbbVie Inc. and Yescarta lymphoma therapy from Gilead Sciences Inc., and will face the price-increase penalty in the form of a rebate.
Photo: Shuran Huang for The Wall Street JournalDiscoveries by National Institutes of Health scientists and grant recipients have been awarded more than 100 Nobel Prizes. The top job at the National Institutes of Health, a prestigious role that has attracted a Nobel Prize winner and other leading scientists, is going unfilled as candidates back out. At least two potential choices for the job have walked away, and the White House has struggled finding qualified candidates willing to fill a job that would probably force them to take a substantial pay cut and face popular attacks on scientists, people familiar with the search said.
WASHINGTON—President Biden marked the first anniversary of the Covid-19 lockdowns two years ago with a high-profile speech, and his administration gave frequent briefings on the topic. Last year, he gave an address on the American Rescue Plan and the country’s economic recovery from the pandemic. On Saturday, the third anniversary of the shutdowns that were triggered by the pandemic, Mr. Biden has no public events planned and his White House has largely shifted focus away from a virus that continues to kill about 2,000 people a week but ranks low among priorities for the American public.
WASHINGTON—Just over a year after going into effect, legislation to protect consumers from unexpected medical bills has hospitals, doctors and insurers fighting over a process that was supposed to help resolve billing disputes. The Department of Health and Human Services was forced to pause an arbitration process used to settle billing disagreements after a federal judge last month vacated parts of the regulation.
Total: 25